KEISER DAVID W 4
4 · ALEXION PHARMACEUTICALS INC · Filed Jun 3, 2009
Insider Transaction Report
Form 4
KEISER DAVID W
Director
Transactions
- Exercise/Conversion
Option to Purchase Common Stock
2009-06-01−4,810→ 0 totalExercise: $20.58From: 2007-04-15Exp: 2017-04-15→ Common Stock, par value $.0001 per share (4,810 underlying) - Exercise/Conversion
Option to Purchase Common Stock
2009-06-01−17,500→ 0 totalExercise: $20.83From: 2007-10-11Exp: 2017-10-11→ Common Stock, par value $.0001 per share (17,500 underlying) - Exercise/Conversion
Common Stock, par value $.0001 per share
2009-06-01$20.83/sh+17,500$364,525→ 184,296 total - Sale
Common Stock, par value $.0001 per share
2009-06-01$36.63/sh−10,000$366,300→ 149,546 total - Exercise/Conversion
Common Stock, par value $.0001 per share
2009-06-01$20.58/sh+2,440$50,215→ 161,986 total - Exercise/Conversion
Common Stock, par value $.0001 per share
2009-06-01$20.58/sh+4,810$98,990→ 166,796 total - Exercise/Conversion
Common Stock, par value $.0001 per share
2009-06-01$32.25/sh+15,250$491,813→ 199,546 total - Sale
Common Stock, par value $.0001 per share
2009-06-01$37.25/sh−1,800$67,050→ 159,546 total - Sale
Common Stock, par value $.0001 per share
2009-06-01$36.59/sh−38,200$1,397,738→ 161,346 total - Exercise/Conversion
Option to Purchase Common Stock
2009-06-01−2,440→ 0 totalExercise: $20.58From: 2007-04-15Exp: 2017-04-15→ Common Stock, par value $.0001 per share (2,440 underlying) - Exercise/Conversion
Option to Purchase Common Stock
2009-06-01−15,250→ 0 totalExercise: $32.25From: 2000-10-31Exp: 2010-10-31→ Common Stock, par value $.0001 per share (15,250 underlying)
Footnotes (4)
- [F1]The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1 (c)(1) of the Securities Exchange Act.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $36.17 - $37.17. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $37.18 - $38.18. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F4]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $36.25 - $37.25. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.